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SUMMARY
Objectives
Chronic Obstructive Pulmonary Disease (COPD) is associated with high mortality and morbidity and is projected 
to be the third most common cause of death worldwide by 2020. For a variety of reasons, there is a drive to man-
age a greater number of individuals as outpatients. Preventing readmissions can reduce associated morbidity and 
subsequent healthcare costs. 
Methods
The aim of the present study was to determine the factors affecting the relapse of COPD exacerbated patients 
in the emergency department (ED). This study combines data from two prospective cohort studies. Patients in-
cluded in the study were above 18 years of age, had a previous diagnosis of COPD, and presented to the ED for the 
treatment of acute exacerbation. All the information relevant to the study was collected during the patient’s visit 
to the ED. Relapse was defined as an unscheduled visit to an ED or primary physician within 2 weeks of initial ED 
visit for worsening COPD symptoms. Telephone follow-up was done on all patients at the end of 2 weeks.
Results
The cohort consists of 196 patients. Relapse rate in this study was 27%. Mean respiratory rate, exacerbations in 
previous year, home nebulizator therapy, home oxygen therapy, admission to intensive care or hospital ward due 
to COPD exacerbation, previous intubation and abnormal chest x-ray were associated with increased re-visit in 
univariate analysis. However, after multivariate analysis, exacerbations in previous year (OR: 1.08, 95%CI: 1.01–
1.15) and abnormal chest X-ray (OR: 2.5, 95%CI: 1.10–6.11) were still significant.
Conclusions
In conclusion, the number of ED visits previous year and abnormal chest x-ray can predict the revisit of a COPD 
exacerbated patient within 14 days of an ED visit.
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Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a chronic 
disorder characterized by irreversible airway obstruction 
and is an important problem of public health. COPD mainly 
occurs due to cigarette smoking, environmental and occu-
pational exposure. This is a costly disease due to frequent 
exacerbations in addition to being a major cause of morta-
lity and morbidity.[1] Exacerbation of COPD is one of the most 
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common reasons for presenting to emergency departments 
(ED). Some of those patients repeatedly present to EDs with 
continuing complaints. Medical doctors have restricted pa-
rameters concerning which patient will present to hospital 
with unending complaints and increasing dyspnea. Altho-
ugh it has been reported in various studies that the patients 
would be presenting to hospital again in case of frequent 
hospital visit within previous year and increasing dyspnea, 
there are not any objective parameters.[2]
The present study is designed to research the factors influ-
encing relapse in patients diagnosed with COPD and pre-
senting to the emergency department with exacerbation. 
Materials and Methods
This prospective cross sectional and clinical study was con-
ducted through the data collected during two separate time 
periods in Akdeniz University, Faculty of Medicine Hospi-
tal, Emergency Department between November 2007-May 
2008 and December 2011-July 2012. The study included the 
patients over 18, presenting to ED with COPD acute attack 
and who were later discharged. Exacerbation of COPD as an 
acute event was considered as defined in GOLD 2013 gui-
delines ‘a worsening of the patient’s respiratory symptoms 
thait is beyond normal day-to-day variations and leads to a 
change in medication’.[3] The patients with the suspicion of 
active pulmonary tuberculosis, with cystic fibrosis diagnosis, 
with a diagnosed bronchiectasis history, and with lung can-
cer were excluded from the study. 
The form used in the study included the following infor-
mation: age, gender, date of presenting, cigarette use (past 
smoker, still smoker, non-smoker), vital findings upon arri-
val and departure from ED (blood pressure, oxygen satu-
ration, respiratory rate, pulse wave velocity, temperature), 
whether arterial blood gas (ABG) values are abnormal or not 
(pH<7.35 or PaO2>60 mmHg or PCO2>45 mmHg accepted 
as abnormal), co-morbid conditions (Hypertension, Diabe-
tes Mellitus, Coronary Heart Disease, Congestive Heart Fa-
ilure, Chronic Renal Failure, Chronic Liver Disease), oxygen 
and nebulizer therapy receiving at home or not, history of 
hospitalization or intensive care requirements, having been 
intubated or not, systemic steroid use, number of presenting 
to ED during the last one year, body mass index, chest radi-
ography abnormality (previous or recent changes in chest 
radiography accepted as abnormal), treatment in ED (ß2 mi-
metic, ipratropium bromide, steroid and dose), presence of 
Anthonisen criteria, possible factor inducing exacerbation 
(infection, wrong drug use), discharge with an unknown re-
ason or pre-hospitalization treatment (antibiotic treatment, 
steroid treatment), discharge/hospitalization status, telep-
hone numbers. 
Anthonisen criteria are a classification used for the severity 
of COPD exacerbation. Those criteria are divided into two 
as major and minor. Increased dyspnea, increased sputum 
volume, and increased sputum purulence are considered as 
major criteria. Minor criteria are the presence of an upper 
respiratory tract infection in the past 5 days, fever without 
any other apparent cause, increased cough or wheezing. 
Type I have all three major criteria, and Type II exhibit two 
major criteria, Type III exacerbations (mild) have one major 
criterion plus one of the minor criteria. 
The patients discharged from ED were called back after 15 
days and were inquired whether they had visited any health 
institution with the same complaints and their responses 
were recorded. 
First group data of the study were published in ‘European 
Journal of Emergency Medicine’ in 2010 and approval for re-
use of some of the data was received from the concerning 
journal.[2] Also, approval from Faculty of Medicine Research 
Ethics Committee was obtained for the second group data. 
Statistical Analysis
Statistical analyses were performed with SPSS Statistics ver-
sion 16.0 (SPSS Inc., Chicago, Illinois, USA). Continuous va-
riables were presented as mean ± standard deviation; for 
non-normally distributed variables, median values and inter-
quartile range were given; variable frequencies were stated 
as percentage. Normality distribution of variables was exa-
mined via both visual (histogram and probabilistic graphs) 
and analytic methods (Kolmogorov-Smirnov). In order for 
group comparison, Student t-test for normally distributed 
variables, Mann-Whitney U test for non-normally distributed 
variables, and χ2 (Chi-square) tests for categorical variables 
were performed. In multivariate analysis, logistic regression 
analysis was performed by employing probable factors de-
termined in previous analyses. The conditions of type I error 
level under 5% were accepted as statistically significant. 
Results
The present study evaluated 196 patients. Development of 
relapse were observed in 54 (27%) of the patients. The study 
group consisted of 92 (47%) males, 104 (53%) females with 
a mean age of 67±10. Demographic details of the patients 
were displayed in Table 1. 
Arterial blood gas values were normal in 107 (55%) and ab-
normal in 65 (34%) of the patients while in 24 (11%) of the 
patients arterial blood gas measurement was not deman-
ded. As a result of co-morbid disease evaluation; it was es-
tablished that of the patients 84 (43%) were with hyperten-
sion, 35 (18%) with diabetes mellitus, 41(%21) with coronary 
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heart disease, 31 (16%) with congestive heart failure, 4(%) 
with chronic renal failure, 2 (2%) with chronic liver disease. 
During discharge of the patients, 83 (42%) were prescribed 
modification in treatment, 45 (25%) were prescribed antibi-
otics, and 71 (36%) were prescribed systemic steroid. Accor-
ding to Anthonisen criteria which are used for the severity of 
symptoms,[4] 45 patients type 1 (severe), 42 patients type 2 
(moderate) and 109 patients were evaluated as type 3 (mild) 
exacerbation.
All in all, average respiratory rate, frequency of exacerbati-
on in previous year, having oxygen and nebulizer therapy at 
home, having a previous history of hospitalization or inten-
sive care requirements, having been intubated due to COPD 
exacerbation, and chest radiography abnormality were fo-
und out to have relationship with relapse in univariate analy-
sis. On the other hand, in multivariate analysis, frequency of 
exacerbation in previous year (OR:1.08, 95%CI: 1.01–1.15) 
and chest radiography abnormality (OR:2.5, 95%CI: 1.10–
6.11) were significant (Table 2). 
Discussion
As a result of the current study, increased application to ED 
due to COPD exacerbation within prior year and abnorma-
lity of chest radiography results found to be significant in 
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Table 1. Demographic attributes
Variables Population Relapse (+) Relapse (–) p
Number of patients 196 142 54  
Mean age (year±SD) 67±10 66±10 69±11 0.13
Sec
 Male 92 68 24 0.66
 Female 104 74 30
Respiratory rate/min 29±7 28±6 31±8 0.03
Body mass index (kg/m2)   25±6.4 24±6.2 0.40
Exacerbation number in last year  2 2 4 0.00
Oxygen therapy at home 55/196 32/142 23/54 0.005
Nebulation therapy at home 94/196 59/142 34/54 0.007
Intensive care unit admission 47/196 26/142 21/54 0.003
Ward admission 136/196 92/142 44/54 0.024
Previous intubation 17/196 7/142 10/54 0.003
Chest X-ray 115/179 75/127 40/52 0.002
Antibiotic use 147/196 105/142 42/54 0.58
SD: Standard deviation.
Table 2. The variables included in logistic regression model in predicting relapse 
Variables OR° (%95 CI) p
Respiratory rate/min 1.05 0.99-1.11 0.06
Exacerbation number in last year 1.08 1.01-1.15 0.02
Oxygen therapy at home 0.64 0.22-1.84 0.41
Nebulation therapy at home 1.62 0.58-4.46 0.34
Intensive care unite admission 1.21 0.43-3.36 0.71
Ward admission 1.87 0.65-5.37 0.24
Previous intubation 1.24 0.27-5.70 0.77
Chest x-ray 2.59 1.10-6.11 0.02
OR: Odds ratio.
terms of relapse prediction. 
Relapse rate was established as 27% in the study. In the pre-
vious studies, relapse rates ranging from 22% to 32% were 
reported.[5] Despite notable progress in health services, simi-
lar relapse rates have been observed since the last decade 
of 1980s.[6] 
Some studies showed that application to ED due to COPD 
exacerbation within prior year could be considered as a 
good parameter for relapse prediction.[7,8] For instance, a 
study by Bhowmik et.al, reported that patients with 3 or 
more frequent exacerbations had higher levels of interleu-
kin 6 (IL-6) and IL-8 in sputum and those patients also had 
more increased airway inflammation.[9] Besides, another 
study by Gompertz et.al, displayed that in sputum of pati-
ents experiencing frequent inflammation, an anti-protease 
concentration called secretory leukopro-teinase inhibitor 
was at low level, which may explain the weakness of anti-
bacterial and viral activities in patients being exposed to fre-
quent inflammation.[10] Also, in another study by Patel et.al, 
it was established that in the airways of patients presenting 
with frequent inflammation, bacterial colonization and IL-6 
levels had been higher.[11] These results might explain why 
relapse is more frequent in those patient group having inc-
reased inflammation and decreased inflammatory response. 
Global Initiative for Chronic Obstructive Lung Disease 2013 
(GOLD 2013) Guidelines declared frequent exacerbation as 
a hospitalization criterion.[3] In order to prevent relapse, the 
patients with frequent exacerbation should be assessed for 
hospitalization. In a study carried out with the patients hos-
pitalized owing to COPD exacerbation and with pre-existent 
severe COPD, hospital mortality was found out to be very 
high.[12] Even though it is difficult to reach the records about 
disease stages in ED conditions, the classification by GOLD 
2013 might be indicative for medical doctors.
In a prospective study by Kim and colleagues, it was stated 
that respiratory rate predicted relapse during admission to 
ED.[8] The study reported that average respiratory rate of pa-
tients per minute in relapse group (n=30) had been 25 while 
it had been 23 in non-relapse group (n=110). Though the 
results are statistically significant, clinical significance and 
indicative strength for medical doctors is debatable. Even 
though in our study average respiratory rate was significant 
in univariate analysis, no difference could be established 
between two groups in multivariate analysis. Dewan and 
colleagues found out in their retrospective study (n=107) 
that oxygen therapy at home and the frequency of exacer-
bation in prior year were the parameters which could pre-
dict relapse.[13] Although utilizing oxygen therapy at home 
was significant in univariate analysis in our study, it was not 
significant in multivariate analysis. It might be thought that 
the patients receiving oxygen therapy at home have advan-
ced stage COPD and even that difference could not have 
been established due to the fact that those patients were 
hospitalized through ED more than others. As mentioned 
before, in the study by Dewan and colleagues, it was found 
out that first group or second group antibiotic intake had 
not influenced relapse. GOLD 2013 guidelines suggest that 
antibiotic should be prescribed in the case of increase in 
dyspnea, sputum volume, and sputum purulence and that 
the choice of the antibiotic should be based on the local 
bacterial resistance pattern. 
In our study the antibiotic class was not recorded but usually 
second generation antibiotics were preferred; however, the 
findings displayed that they were ineffective on relapse. 
In a prospective study evaluating the patients presenting to 
family physician due to COPD exacerbation and the exami-
ning the factors influencing relapse within 30 days, ischemic 
heart disease, the degree of dyspnea and, history of hospital 
admission due to exacerbation were found significant.[14] Ho-
wever, the results in that study might have been affected by 
the foreseen period of 30 days. In our previous study related 
to COPD and relapse, the assessment performed by using 
two different visual analog scales for the degree of dyspnea 
including the time of ED admission and of pre-discharge 
showed that the degree of dyspnea was not significant in 
predicting relapse.[2] Besides, in patients presenting to family 
physician and to ED due to COPD exacerbation, the severity 
of exacerbation might not be equal. 
Because of the similar pace of COPD exacerbation rates 
during the last 30 years and high hospital bed occupancy 
rate during winter months when exacerbation density is 
high, establishment of observation units may be an effec-
tive alternative for the care period of those patients. In re-
lation to that, in a study by Salazar and colleagues, inpati-
ent treatment (n=1961) and follow-up at observation unit 
(n=545) were compared retrospectively and it revealed that 
the duration of hospital stay for inpatient treatment was 12 
days while it was 3.4 days for follow-up at observation unit 
(p<0.001). In the same study, hospital admission rates for the 
second time within 10 days were 7% for inpatient treatment 
and 9.9% for follow-up at observation unit (p=0.02). Altho-
ugh in this study second time hospital admission was based 
on 10 days, very low level of relapse rate in both conditions 
and 3.4 days average stay duration in observation unit might 
be beneficial for the care process of those patients.[15] 
As a surprising result of this study, some of the objective pa-
rameters (respiratory rate at the time of presenting to ED, 
blood pressure, pulse rate, blood gas, chest radiography, 
body mass index) were not found useful in predicting relap-
se within two weeks. This might be explained by much more 
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hospitalization of patients with abnormal vital findings. 
In conclusion, it might be said that the patients presenting 
to ED with COPD exacerbation, with frequent COPD exacer-
bation in previous year, and with abnormal chest radiog-
raphy are more likely to have relapse. Hence, it will be ad-
vantageous for the ED physicians to keep this condition in 
mind during the caring of those patients.
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